This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Top Midday Stories: Tesla, GM Report Vehicle Deliveries; Biden, Sanders Say Novo Nordisk, Eli Lilly Charge 'Unconscionably' High Prices; Warner Bros. Interested in Deal With Paramount MT
Moderna, Pfizer-BioNTech COVID-19 Vaccine Patent Legal Battle Gets Mixed UK Ruling MT
Pfizer-BioNTech, Moderna Set to Appeal Mixed UK Ruling in COVID-19 Vaccine Patent Case MT
Pfizer: new member elected to the Board of Directors CF
Vaxcyte Appoints John Furey to Board of Directors CI
US DOJ informs Viatris' Mylan is no longer part of antitrust investigation RE
Delaware Judge Rejects Drugmakers' Appeal to End Zantac Lawsuits MT
UK court gives mixed ruling in Pfizer v Moderna COVID vaccine patents case RE
Drugmakers' appeal to end Zantac cancer lawsuits rebuffed by judge RE
Vera Therapeutics Appoints David Johnson as Chief Operating Officer MT
Pfizer Inc Appoints Cyrus Taraporevala to Board of Directors, Audit Committee and Compensation Committee CI
Tiny Chain Bridge is top banker to Trump, Republican campaigns RE
Pfizer: CHMP recommends new Covid vaccine CF
Would you like some more inflation? Our Logo
EMA Says CHMP Gave Positive Opinion For mResvia RSV mRNA Vaccine For Prevention In Adults 60 Years And Older RE
Pfizer Inc.(NYSE:PFE) dropped from Russell Top 50 Index CI
Pfizer, BioNTech Get Positive Committee Opinion for Omicron JN.1-Adapted COVID-19 Vaccine in European Union MT
Pfizer, BioNTech Get Positive CHMP Opinion for New Covid-19 Vaccine DJ
Immunome, Inc. Appoints Phil Tsai as Chief Technical Officer CI
GSK Shares Slump After CDC Narrows Age Recommendation for RSV Shots DJ
CDC Updates RSV Shot Recommendation Among the Elderly; Vaccine Makers Mixed Pre-Bell MT
Nervy trade in London before US data AN
Pfizer Keeps Q3 Dividend at $0.42 a Share, Payable Sept. 3 to Holders of Record July 26 MT
Pfizer Inc. Declares Third-Quarter 2024 Dividend on the Company?s Common Stock, Payable on September 3, 2024 CI
Moderna Shares Fall as RSV Shot Efficacy Lags Behind Rivals' Vaccines, CDC Data Shows MT
Chart Pfizer, Inc.
More charts
Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
24
Last Close Price
27.83 USD
Average target price
31.92 USD
Spread / Average Target
+14.68%
Consensus
  1. Stock Market
  2. Equities
  3. PFE Stock
  4. News Pfizer, Inc.
  5. Morgan Stanley Lifts Price Target on Pfizer to $29 From $28, Keeps Equalweight Rating